Millenium Healthcare Inc (MHCC) 0.1331 $MHCC
Millennium Healthcare Expands Management Team With the Appointment of Pharma Veteran Paul Antogiovanni as Senior Vice President, Oncology Products
Marketwired - Thu Dec 04, 12:06PM CST
Millennium Healthcare Inc. (OTCQB: MHCC) announces the expansion of its executive management team with the appointment of Paul Antogiovanni as senior vice president of oncology products. In this newly created position, Mr. Antogiovanni is responsible for the company's commercial activities including expanding sales channels and vetting new products to acquire.
Millennium Healthcare to Hold Business Update Conference Call on December 2nd
Marketwired - Mon Nov 24, 7:04AM CST
Millennium Healthcare Inc. (OTCQB: MHCC) today announced that it will host a conference call for investors on Tuesday, December 2, 2014 beginning at 4:30 p.m. ET. Dominick Sartorio, chief executive officer of Millennium Healthcare, and David Perry, chief operating officer will review the third quarter of 2014 and provide a business update. A question and answer session will follow formal remarks made by management.
Millennium Healthcare Provides Details on Its Diagnostic Devices
Marketwired - Thu Nov 20, 2:04PM CST
Millennium Healthcare Inc. (OTCQB: MHCC) today provided details on its sales and distribution model as well as an update on Millennium Medical Devices (MMD) as it advances a commercial strategy with efficient use of sales resources and a creative marketing approach. MMD is a wholly owned subsidiary of Millennium Healthcare.
Millennium Healthcare Secures Three Additional New Sales, Marketing and Distribution Agreements
Marketwired - Wed Nov 12, 9:34AM CST
Millennium Healthcare Inc. (OTCQB: MHCC) today announced that its wholly owned subsidiary, Millennium Medical Devices, has executed additional sales, marketing and distribution agreements with three US based healthcare organizations. These new agreements are anticipated to help provide additional market exposure and expansion into new geographical markets for Millennium.
These Small-Cap Marijuana Stocks are in Play Next Week
ACCESSWIRE - Fri Oct 31, 11:35AM CDT
Coral Gables, FL / ACCESSWIRE / October 31, 2014 / ViaDerma, Inc. (OTCQB: VDRM) ecently released a revolutionary new wound care drug called TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs. The drug is FDA registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns, but has also shown to be effective in fighting methicillin-resistant Staphyloccus aureus (MRSA) infections.
Millennium Healthcare Reports Record Third Quarter Revenue
Marketwired - Wed Oct 29, 7:32AM CDT
Millennium Healthcare Inc. (OTCQB: MHCC) today announced that revenues for the three months ended September 30, 2014 are expected to be in excess of $6.0 million. This represents significant growth compared with revenue of $490,000 for the comparable 2013 period, and was largely the result of the initial roll out of the Company's medical device distribution model. During the quarter Millennium Healthcare began the commercial introduction of its first two distributed medical device products, namely VasoScan(TM), a cardiovascular diagnostic assessment test, and OralCDx(TM), a non-invasive brush biopsy kit for oral cancer. Millennium intends to continue its model and mission of evaluating early detection and diagnostic devices and continually looks to add and provide additional products to its medical device lines available for distribution.
Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement
PR Newswire - Tue Sep 30, 7:30AM CDT
Millennium Healthcare Inc. (MHCC) today announced that its subsidiary, Millennium Medical Devices, has executed a sales, marketing and distribution agreement with MDbizWorx. MDbizWorx is a Florida based provider of ancillary medical services that serves private physician practices, Accountable Care Organizations (ACOs) and hospitals through a seasoned national marketing and sales force. MDbizWorx currently serves over 10,400 active Physician Purchasing Accounts that include a network database of over 300,000 physicians. Robert Toppi, Director of Operations of MDbizWorx stated, "I cannot express enough how we can help Millennium Medical Devices attain many of their short and long term goals. Their diagnostic testing will fill the long missing service line that we had been set on marketing."
Millennium HealthCare CEO Dominick Sartorio Featured on the Cover of MicroCap Review Magazine
PR Newswire - Wed Sep 03, 7:30AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) Chief Executive Officer Dominick Sartorio will be featured on the cover of the Summer/Fall 2014 issue of MicroCap Review Magazine, a SNN Incorporated publication. A story about Millennium HealthCare and Mr. Sartorio will appear in a three-page article in the Profiled Companies section of the magazine. The article can be found on pages 22 through 24 of the issue.
Millennium Healthcare CEO Reports on Operational Developments and Progress
PR Newswire - Thu Aug 21, 8:08AM CDT
Millennium Healthcare Inc. (OTCBB: MHCC) today issued a statement from its Chief Executive Officer, Dominick Sartorio, providing an update on recent corporate developments. The statement is included in its entirety below:
Millennium Healthcare Working to Help Prevent Oral Cancers With the OralCDx Brush Biopsy Test
PR Newswire - Wed Jun 25, 7:30AM CDT
Millennium HealthCare Inc. (MHCC) through its subsidiary, Millennium Medical Devices LLC, has an exclusive agreement with CDx Diagnostics to distribute its OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test dysplasia (the small white and red tissue spots commonly found in the mouth) to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
Millennium Healthcare Inc. Advances Patient Care With VasoScan Cardiovascular Assessment Test
PR Newswire - Mon Jun 23, 8:27AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) through its wholly owned subsidiary, Millennium Medical Devices, LLC is assisting primary care physicians to offer their patients breakthrough diagnostics that are reimbursable by Medicare and private insurance companies.
Millennium Medical Devices Begins Rollout of CDx Diagnostics' OralCDx Brush Biopsy Test
PR Newswire - Wed Feb 12, 7:31AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, through a signed exclusive agreement with CDx Diagnostics, will begin its rollout and distribution of the OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test the small white and red tissue spots commonly found in the mouth to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
Millennium Healthcare Expands Management Team With the Appointment of Pharma Veteran Paul Antogiovanni as Senior Vice President, Oncology Products
Marketwired - Thu Dec 04, 12:06PM CST
Millennium Healthcare Inc. (OTCQB: MHCC) announces the expansion of its executive management team with the appointment of Paul Antogiovanni as senior vice president of oncology products. In this newly created position, Mr. Antogiovanni is responsible for the company's commercial activities including expanding sales channels and vetting new products to acquire.
Millennium Healthcare to Hold Business Update Conference Call on December 2nd
Marketwired - Mon Nov 24, 7:04AM CST
Millennium Healthcare Inc. (OTCQB: MHCC) today announced that it will host a conference call for investors on Tuesday, December 2, 2014 beginning at 4:30 p.m. ET. Dominick Sartorio, chief executive officer of Millennium Healthcare, and David Perry, chief operating officer will review the third quarter of 2014 and provide a business update. A question and answer session will follow formal remarks made by management.
Millennium Healthcare Provides Details on Its Diagnostic Devices
Marketwired - Thu Nov 20, 2:04PM CST
Millennium Healthcare Inc. (OTCQB: MHCC) today provided details on its sales and distribution model as well as an update on Millennium Medical Devices (MMD) as it advances a commercial strategy with efficient use of sales resources and a creative marketing approach. MMD is a wholly owned subsidiary of Millennium Healthcare.
Millennium Healthcare Secures Three Additional New Sales, Marketing and Distribution Agreements
Marketwired - Wed Nov 12, 9:34AM CST
Millennium Healthcare Inc. (OTCQB: MHCC) today announced that its wholly owned subsidiary, Millennium Medical Devices, has executed additional sales, marketing and distribution agreements with three US based healthcare organizations. These new agreements are anticipated to help provide additional market exposure and expansion into new geographical markets for Millennium.
These Small-Cap Marijuana Stocks are in Play Next Week
ACCESSWIRE - Fri Oct 31, 11:35AM CDT
Coral Gables, FL / ACCESSWIRE / October 31, 2014 / ViaDerma, Inc. (OTCQB: VDRM) ecently released a revolutionary new wound care drug called TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs. The drug is FDA registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns, but has also shown to be effective in fighting methicillin-resistant Staphyloccus aureus (MRSA) infections.
Millennium Healthcare Reports Record Third Quarter Revenue
Marketwired - Wed Oct 29, 7:32AM CDT
Millennium Healthcare Inc. (OTCQB: MHCC) today announced that revenues for the three months ended September 30, 2014 are expected to be in excess of $6.0 million. This represents significant growth compared with revenue of $490,000 for the comparable 2013 period, and was largely the result of the initial roll out of the Company's medical device distribution model. During the quarter Millennium Healthcare began the commercial introduction of its first two distributed medical device products, namely VasoScan(TM), a cardiovascular diagnostic assessment test, and OralCDx(TM), a non-invasive brush biopsy kit for oral cancer. Millennium intends to continue its model and mission of evaluating early detection and diagnostic devices and continually looks to add and provide additional products to its medical device lines available for distribution.
Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement
PR Newswire - Tue Sep 30, 7:30AM CDT
Millennium Healthcare Inc. (MHCC) today announced that its subsidiary, Millennium Medical Devices, has executed a sales, marketing and distribution agreement with MDbizWorx. MDbizWorx is a Florida based provider of ancillary medical services that serves private physician practices, Accountable Care Organizations (ACOs) and hospitals through a seasoned national marketing and sales force. MDbizWorx currently serves over 10,400 active Physician Purchasing Accounts that include a network database of over 300,000 physicians. Robert Toppi, Director of Operations of MDbizWorx stated, "I cannot express enough how we can help Millennium Medical Devices attain many of their short and long term goals. Their diagnostic testing will fill the long missing service line that we had been set on marketing."
Millennium HealthCare CEO Dominick Sartorio Featured on the Cover of MicroCap Review Magazine
PR Newswire - Wed Sep 03, 7:30AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) Chief Executive Officer Dominick Sartorio will be featured on the cover of the Summer/Fall 2014 issue of MicroCap Review Magazine, a SNN Incorporated publication. A story about Millennium HealthCare and Mr. Sartorio will appear in a three-page article in the Profiled Companies section of the magazine. The article can be found on pages 22 through 24 of the issue.
Millennium Healthcare CEO Reports on Operational Developments and Progress
PR Newswire - Thu Aug 21, 8:08AM CDT
Millennium Healthcare Inc. (OTCBB: MHCC) today issued a statement from its Chief Executive Officer, Dominick Sartorio, providing an update on recent corporate developments. The statement is included in its entirety below:
Millennium Healthcare Working to Help Prevent Oral Cancers With the OralCDx Brush Biopsy Test
PR Newswire - Wed Jun 25, 7:30AM CDT
Millennium HealthCare Inc. (MHCC) through its subsidiary, Millennium Medical Devices LLC, has an exclusive agreement with CDx Diagnostics to distribute its OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test dysplasia (the small white and red tissue spots commonly found in the mouth) to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
Millennium Healthcare Inc. Advances Patient Care With VasoScan Cardiovascular Assessment Test
PR Newswire - Mon Jun 23, 8:27AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) through its wholly owned subsidiary, Millennium Medical Devices, LLC is assisting primary care physicians to offer their patients breakthrough diagnostics that are reimbursable by Medicare and private insurance companies.
Millennium Medical Devices Begins Rollout of CDx Diagnostics' OralCDx Brush Biopsy Test
PR Newswire - Wed Feb 12, 7:31AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, through a signed exclusive agreement with CDx Diagnostics, will begin its rollout and distribution of the OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test the small white and red tissue spots commonly found in the mouth to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
